drugset / Trial / NCT04711213

A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

NCT04711213 ↗

Phase 2 Completed 60 enrolled iDrop, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo eye drops to determine if the drops decrease inflammation and pain inside the eye and are safe after cataract surgery.

Timeline

Start
2020-09-14
Primary completion
2020-10-31
Completion
2020-11-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule — Other

Indications